MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3389/fneur.2025.1614862

Медицинская библиотека · Frontiers in neurology · 2026

The association between blood urea nitrogen to albumin ratio and cognitive function in Parkinson's disease patients.

Zhou Wen, Xia Qingqing, Liu Duan, Zeng Tian-Fang, Pang Rui-Juan, Li Jun-Ying, Gong Liang

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Cognitive impairment is a significant complication in Parkinson's disease (PD), impacting quality of life and increasing caregiver burden. This study investigates the association between the blood urea nitrogen to albumin ratio (BAR) and cognitive impairment in PD patients, aiming to identify BAR as a potential biomarker for early detection and monitoring of cognitive decline.

METHODS

Data from 1,312 PD patients were extracted from the PPMI database. The cognitive assessment tool was the Montreal Cognitive Assessment (MoCA) score and other cognitive metrics. The association between BAR and cognitive impairment was assessed using multivariate linear regression models to evaluate the continuous relationship, and logistic regression models to examine the binary outcomes. Furthermore, subgroup and sensitivity analyses were carried out to ensure the reliability of the results.

RESULTS

Higher BAR levels were significantly associated with lower MoCA scores in PD patients, independent of other confounding variables (β = -0.21, 95% CI = -0.35 ~ -0.07, p = 0.003). The odds ratio for cognitive impairment, defined by a MoCA score cutoff of 26, was 1.15 (95% CI: 1.02-1.30, p = 0.027). Further analysis revealed that BAR was negatively correlated with the Benton Judgment of Line Orientation MOANS Scale Score and the Symbol-Digit Modalities Test T-score, and positively correlated with the Trail Making Test Part A Reverse Z-score. These findings suggest that higher BAR levels are associated with poorer performance in visuospatial abilities, processing speed, and motor function.

CONCLUSION

This study underscores the potential utility of BAR as a biomarker for cognitive impairment in PD. Future prospective cohort studies are warranted to validate these findings and explore the potential of BAR in clinical practice.

Для цитирования: Zhou Wen, Xia Qingqing, Liu Duan, Zeng Tian-Fang, Pang Rui-Juan, Li Jun-Ying, Gong Liang. The association between blood urea nitrogen to albumin ratio and cognitive function in Parkinson's disease patients.. Frontiers in neurology. 2026. DOI: 10.3389/fneur.2025.1614862.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.